Li Shu, Wu Chao, Gao Hongliang, Wu Xiuwei, Yu Le, Tao Bangbao, Hong Yun
Department of Pathophysiology, Wannan Medical College Wuhu, China.
Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University Hefei, China.
Int J Clin Exp Pathol. 2018 Mar 1;11(3):1538-1545. eCollection 2018.
CD151 is up-regulated in several types of tumors and is involved in tumor invasion and metastasis. However, the potential role of CD151 in pituitary adenomas remains unclear. Here, we performed quantitative real-time PCR and immunochemistry to measure the expression levels of CD151 in samples of pituitary adenomas and investigated the effects of CD151 knock-down on tumor phenotypes in the HP75 pituitary adenoma cell line. We found that, compared to normal pituitary tissues, CD151 expression is increased in non-invasive pituitary adenomas and further increased in invasive pituitary adenomas. CD151 knock-down inhibited cell proliferation, invasion, clone formation, tumor development, and promoted apoptosis in the pituitary adenoma cell line. Our results fully support that CD151 plays an important role in promoting invasion and aggression of pituitary adenomas and thus might be a therapeutic target.
CD151在多种肿瘤类型中表达上调,并参与肿瘤侵袭和转移。然而,CD151在垂体腺瘤中的潜在作用仍不清楚。在此,我们进行了定量实时PCR和免疫化学检测,以测定垂体腺瘤样本中CD151的表达水平,并研究了在HP75垂体腺瘤细胞系中敲低CD151对肿瘤表型的影响。我们发现,与正常垂体组织相比,CD151在非侵袭性垂体腺瘤中表达增加,而在侵袭性垂体腺瘤中进一步增加。敲低CD151可抑制垂体腺瘤细胞系中的细胞增殖、侵袭、克隆形成、肿瘤发展,并促进细胞凋亡。我们的结果充分支持CD151在促进垂体腺瘤侵袭和进展中起重要作用,因此可能是一个治疗靶点。